Skip to content

Glymphatic MRI Study

Evaluation of Glymphatic Function With MRI

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06452459
Enrollment
10
Registered
2024-06-11
Start date
2024-07-01
Completion date
2028-07-01
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Deprivation

Brief summary

This study aims at identifying neuroimaging markers of glymphatic function in humans.

Interventions

OTHERNo interventinon

No intervention is anticipated. This is an observational study.

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years

Inclusion criteria

* Ability to undergo MRI without anesthesia * Calculated GFR greater or equal to 60 mL/min/1.73 m2

Exclusion criteria

* Inability to obtain consent * Subject is incarcerated, pregnant, or lactating or suspects they may be pregnant * Known allergic or hypersensitivity reactions to gadolinium * Three or more drug allergies from separate drug classes * Recent or expected beed for imaging with iodinated contrast * Contraindications to MRI: claustrophobia, weight greater than maximum MRI scanner capacity, presence of metallic foreign body, or implanted devices not documented as MRI safe * History of neurosurgical procedure or cervical surgery * Current use of anticoagulation medications * Contraindication to lumbar puncture (creatinine or INR elevated above laboratory standard cutoffs)

Design outcomes

Primary

MeasureTime frameDescription
Contrast enhancement2 weeksMeasurement of contrast intensity in brain parenchyma

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026